Nature Communications,
Journal Year:
2021,
Volume and Issue:
12(1)
Published: Oct. 18, 2021
Abstract
Large-scale
profiling
of
intact
glycopeptides
is
critical
but
challenging
in
glycoproteomics.
Data
independent
acquisition
(DIA)
an
emerging
technology
with
deep
proteome
coverage
and
accurate
quantitative
capability
proteomics
studies,
still
the
early
stage
development
field
We
propose
GproDIA,
a
framework
for
proteome-wide
characterization
from
DIA
data
comprehensive
statistical
control
by
2-dimentional
false
discovery
rate
approach
glycoform
inference
algorithm,
enabling
identification
using
wide
isolation
windows.
further
utilize
semi-empirical
spectrum
prediction
strategy
to
expand
spectral
libraries
glycopeptides.
benchmark
our
method
N-glycopeptide
on
yeast
human
serum
samples,
demonstrating
that
GproDIA
outperforms
data-dependent
acquisition-based
methods
glycoproteomics
terms
capacity
completeness
identification,
as
well
accuracy
precision
quantification.
expect
this
work
can
provide
powerful
tool
glycoproteomic
studies.
Signal Transduction and Targeted Therapy,
Journal Year:
2021,
Volume and Issue:
6(1)
Published: Nov. 15, 2021
Coronavirus
disease
2019
(COVID-19),
a
highly
infectious
caused
by
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
has
infected
more
than
235
million
individuals
and
led
to
4.8
deaths
worldwide
as
of
October
5
2021.
Cryo-electron
microscopy
topology
show
that
the
SARS-CoV-2
genome
encodes
lots
glycosylated
proteins,
such
spike
(S),
envelope
(E),
membrane
(M),
ORF3a
which
are
responsible
for
host
recognition,
penetration,
binding,
recycling
pathogenesis.
Here
we
reviewed
detections,
substrates,
biological
functions
glycosylation
in
proteins
well
human
receptor
ACE2,
also
summarized
approved
undergoing
therapeutics
associated
with
glycosylation.
This
review
may
not
only
broad
understanding
viral
glycobiology,
but
provide
key
clues
development
new
preventive
therapeutic
methodologies
against
its
variants.
Nature Communications,
Journal Year:
2022,
Volume and Issue:
13(1)
Published: April 7, 2022
Abstract
Glycopeptides
with
unusual
glycans
or
poor
peptide
backbone
fragmentation
in
tandem
mass
spectrometry
are
unaccounted
for
typical
site-specific
glycoproteomics
analysis
and
thus
remain
unidentified.
Here,
we
develop
a
tool,
Glyco-Decipher,
to
address
these
issues.
Glyco-Decipher
conducts
glycan
database-independent
matching
exploits
the
pattern
of
shared
backbones
glycopeptides
improve
spectrum
interpretation.
We
benchmark
on
several
large-scale
datasets,
demonstrating
that
it
identifies
more
peptide-spectrum
matches
than
Byonic,
MSFragger-Glyco,
StrucGP
pGlyco
3.0,
33.5%-178.5%
increase
number
identified
glycopeptide
spectra.
The
unbiased
profiling
attached
enables
discovery
164
modified
mouse
tissues,
including
chemical
biological
modifications.
By
enabling
in-depth
characterization
protein
glycosylation,
is
promising
tool
advancing
research.
Cell Reports,
Journal Year:
2025,
Volume and Issue:
44(1), P. 115168 - 115168
Published: Jan. 1, 2025
Highlights•Cryo-EM
structure
of
EBV
gp350-CR2
complex
at
a
resolution
3.29
ŕDepiction
polar
and
glycan-free
contacting
interface•Key
residue
divergence
in
CR2
affects
host
tropism•Designed
CR2-Fc
neutralizes
B
cell
infection
by
targeting
72A1
epitopeSummaryEpstein-Barr
virus
(EBV)
is
an
oncogenic
associated
with
multiple
lymphoid
malignancies
autoimmune
diseases.
During
cells,
uses
its
major
glycoprotein
gp350
to
recognize
the
receptor
CR2,
initiating
viral
attachment,
process
that
has
lacked
direct
structural
evidence
for
decades.
In
this
study,
we
resolved
complex,
elucidated
their
key
interactions,
determined
site-specific
N-glycosylation
map
gp350.
Our
findings
reveal
primarily
binds
through
electrostatically
complementary
interface
diversity
residues
across
different
species
influences
selectivity
mediated
With
confirmed
binding,
constructed
antibody
analog
targets
vulnerable
site
gp350,
demonstrating
potent
neutralization
effect
against
cells.
work
provides
essential
insights
into
mechanism
tropism,
suggesting
potential
antiviral
agent.Graphical
abstract
Theranostics,
Journal Year:
2023,
Volume and Issue:
13(8), P. 2605 - 2615
Published: Jan. 1, 2023
Cell
surface
glycosylation
has
a
variety
of
functions,
and
its
dysregulation
in
cancer
contributes
to
impaired
signaling,
metastasis
the
evasion
immune
responses.Recently,
number
glycosyltransferases
that
lead
altered
have
been
linked
reduced
anti-tumor
responses:
B3GNT3,
which
is
implicated
PD-L1
triple
negative
breast
cancer,
FUT8,
through
fucosylation
B7H3,
B3GNT2,
confers
resistance
T
cell
cytotoxicity.Given
increased
appreciation
relevance
protein
glycosylation,
there
critical
need
for
development
methods
allow
an
unbiased
interrogation
status.Here
we
provide
overview
broad
changes
at
describe
selected
examples
receptors
with
aberrant
leading
functional
changes,
emphasis
on
checkpoint
inhibitors,
growth-promoting
growth-arresting
receptors.Finally,
posit
field
glycoproteomics
matured
extent
where
large-scale
profiling
intact
glycopeptides
from
feasible
poised
discovery
new
actionable
targets
against
cancer.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: July 12, 2023
Abstract
Post-translational
modifications
are
an
area
of
great
interest
in
mass
spectrometry-based
proteomics,
with
a
surge
methods
to
detect
them
recent
years.
However,
post-translational
can
introduce
complexity
into
proteomics
searches
by
fragmenting
unexpected
ways,
ultimately
hindering
the
detection
modified
peptides.
To
address
these
deficiencies,
we
present
fully
automated
method
find
diagnostic
spectral
features
for
any
modification.
The
be
incorporated
search
engines
improve
peptide
recovery
and
localization.
We
show
utility
this
approach
interrogating
fragmentation
patterns
cysteine-reactive
chemoproteomic
probe,
RNA-crosslinked
peptides,
sialic
acid-containing
glycopeptides,
ADP-ribosylated
also
analyze
interactions
between
ion’s
intensity
its
statistical
properties.
This
has
been
open-search
annotation
tool
PTM-Shepherd
FragPipe
computational
platform.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: March 19, 2024
Abstract
Deep
learning
has
achieved
a
notable
success
in
mass
spectrometry-based
proteomics
and
is
now
emerging
glycoproteomics.
While
various
deep
models
can
predict
fragment
spectra
of
peptides
with
good
accuracy,
they
cannot
cope
the
non-linear
glycan
structure
an
intact
glycopeptide.
Herein,
we
present
DeepGlyco,
learning-based
approach
for
prediction
glycopeptides.
Our
model
adopts
tree-structured
long-short
term
memory
networks
to
process
moiety
graph
neural
network
architecture
incorporate
potential
fragmentation
pathways
specific
structure.
This
feature
beneficial
explainability
differentiation
ability
structural
isomers.
We
further
demonstrate
that
predicted
spectral
libraries
be
used
data-independent
acquisition
glycoproteomics
as
supplement
library
completeness.
expect
this
work
will
provide
valuable
resource